These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 1337553
41. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. Müller O. J Antimicrob Chemother; 1996 Jun; 37 Suppl C():83-92. PubMed ID: 8818849 [Abstract] [Full Text] [Related]
42. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia. Myburgh J, Nagel GJ, Petschel E. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():163-9. PubMed ID: 8396088 [Abstract] [Full Text] [Related]
44. [Clinical efficacy of clarithromycin in the field of pediatrics]. Ogura H, Kubota H, Nomura I, Tomoda T, Araki K, Ogura Y, Kurashige T. Jpn J Antibiot; 1989 Feb; 42(2):401-10. PubMed ID: 2526253 [Abstract] [Full Text] [Related]
45. Once-daily azithromycin in the treatment of adult skin and skin-structure infections. Amaya-Tapia G, Aguirre-Avalos G, Andrade-Villanueva J, Peredo-González G, Morfín-Otero R, Esparza-Ahumada S, Rodríguez-Noriega E. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():129-35. PubMed ID: 8396084 [Abstract] [Full Text] [Related]
46. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. Khan WA, Saha D, Rahman A, Salam MA, Bogaerts J, Bennish ML. Lancet; 2002 Nov 30; 360(9347):1722-7. PubMed ID: 12480424 [Abstract] [Full Text] [Related]
48. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. Gris P. J Antimicrob Chemother; 1996 Jun 30; 37 Suppl C():93-101. PubMed ID: 8818850 [Abstract] [Full Text] [Related]
49. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. Schönwald S, Gunjaca M, Kolacny-Babić L, Car V, Gosev M. J Antimicrob Chemother; 1990 Jan 30; 25 Suppl A():123-6. PubMed ID: 2154431 [Abstract] [Full Text] [Related]
51. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. Mallory SB. Am J Med; 1991 Sep 12; 91(3A):36S-39S. PubMed ID: 1656741 [Abstract] [Full Text] [Related]
55. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Peters DH, Clissold SP. Drugs; 1992 Jul 12; 44(1):117-64. PubMed ID: 1379907 [Abstract] [Full Text] [Related]
56. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Dunn CJ, Barradell LB. Drugs; 1996 Mar 12; 51(3):483-505. PubMed ID: 8882383 [Abstract] [Full Text] [Related]
57. [Laboratory and clinical studies on clarithromycin in pediatrics]. Akita H, Sato Y, Iwata S, Sunakawa K. Jpn J Antibiot; 1989 Feb 12; 42(2):264-79. PubMed ID: 2526242 [Abstract] [Full Text] [Related]
58. Azithromycin and lower respiratory tract infections. Blasi F, Cazzola M, Tarsia P, Cosentini R, Aliberti S, Santus P, Allegra L. Expert Opin Pharmacother; 2005 Oct 12; 6(13):2335-51. PubMed ID: 16218893 [Abstract] [Full Text] [Related]
59. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group. Daniel R. J Int Med Res; 1991 Oct 12; 19(6):433-45. PubMed ID: 1663466 [Abstract] [Full Text] [Related]
60. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Vallée E, Azoulay-Dupuis E, Pocidalo JJ, Bergogne-Bérézin E. Antimicrob Agents Chemother; 1992 Jul 12; 36(7):1412-7. PubMed ID: 1324644 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]